We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

61 hedge funds and large institutions have $251M invested in Oxford Immunotec Global PLC Ordinary Shares in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

218% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 11

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

5% more funds holding

Funds holding: 58 → 61 (+3)

1% more capital invested

Capital invested by funds: $249M → $251M (+$1.65M)

Holders
61
Holders Change
+3
Holders Change %
+5.17%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
7
Increased
35
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$5.94M
2
PC
Polar Capital
United Kingdom
+$5M
3
Axa
Axa
France
+$1.85M
4
BFA
BlackRock Fund Advisors
California
+$872K
5
GPGA
Grandeur Peak Global Advisors
Utah
+$730K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$4.76M
2
CV
Clarus Ventures
Massachusetts
-$2.76M
3
RG
Redmile Group
California
-$2.74M
4
KCM
Kornitzer Capital Management
Kansas
-$1.58M
5
Ameriprise
Ameriprise
Minnesota
-$482K
Name Holding Trade Value Shares
Change 		Change in
Stake
CWG
26
C WorldWide Group
Denmark
$1.67M – – –
UOC
27
UBS O'Connor
Illinois
$1.19M +$148K +10,910 +15%
GIP
28
Granite Investment Partners
California
$985K +$123K +9,130 +15%
BIM
29
BlackRock Investment Management
Delaware
$974K +$298K +22,027 +46%
TCIM
30
TIAA CREF Investment Management
New York
$893K +$183K +13,526 +27%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$759K +$150K +11,126 +25%
WA
32
Wasatch Advisors
Utah
$720K +$703K +51,982 New
FA
33
Friess Associates
Delaware
$668K -$16K -1,185 -2%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$509K +$87.2K +6,448 +21%
Vanguard Group
35
Vanguard Group
Pennsylvania
$474K +$98.4K +7,276 +27%
PSC
36
Piper Sandler & Co
Minnesota
$416K +$3.38K +250 +0.8%
Charles Schwab
37
Charles Schwab
California
$408K – – –
TA
38
Teachers Advisors
New York
$407K +$98.4K +7,278 +33%
Renaissance Technologies
39
Renaissance Technologies
New York
$356K +$89.3K +6,600 +35%
Geode Capital Management
40
Geode Capital Management
Massachusetts
$327K +$41.7K +3,085 +15%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$266K +$260K +19,238 New
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$239K +$29.2K +2,160 +14%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$218K +$35.8K +2,650 +20%
Wells Fargo
44
Wells Fargo
California
$205K -$4.76M -351,895 -96%
CS
45
Credit Suisse
Switzerland
$183K +$179K +13,234 New
NFA
46
Nationwide Fund Advisors
Ohio
$178K +$39.1K +2,890 +29%
AIG
47
American International Group
New York
$163K +$49.1K +3,627 +44%
BA
48
BlackRock Advisors
Delaware
$140K +$24.3K +1,794 +22%
Citigroup
49
Citigroup
New York
$123K -$424K -31,365 -78%
Deutsche Bank
50
Deutsche Bank
Germany
$67K +$65.4K +4,837 +161,233%
1
2
3

OXFD Hedge Fund Activity: Q2 2015 in Review

61 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q2 2015, worth a combined $251M — up 0.66% from $249M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new OXFD positions and 4 closed out — a net gain of 3 holders — while 35 added to existing stakes and 11 trimmed.

The largest buyer was OppenheimerFunds, adding an estimated $5.94M. The largest seller was Wells Fargo, cutting an estimated $4.76M.

  • 61 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q2 2015, up from 58 in Q1 2015.
  • Funds reported $251M of Oxford Immunotec Global PLC Ordinary Shares stock for Q2 2015, up 0.66% quarter-over-quarter.
  • 7 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q2 2015 and 4 closed out, a net change of +3 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q2 2015 was OppenheimerFunds, an estimated $5.94M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q2 2015 was Wells Fargo, an estimated $4.76M sold.

Based on aggregated 13F filings for Q2 2015.